Single center study of Eculizumab in Highly Sensitized Patients Undergoing Heart Transplantation
Latest Information Update: 15 Jun 2022
At a glance
- Drugs Eculizumab (Primary)
- Indications Heart transplant rejection
- Focus Therapeutic Use
Most Recent Events
- 15 Jun 2022 New trial record
- 30 Apr 2022 Results presented at the 42nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation